Literature DB >> 21235237

Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.

Katherine L Germane1, Benjamin W Spiller.   

Abstract

Bacterial pathogens secrete effectors into their hosts that subvert host defenses and redirect host processes. EspG is a type three secretion effector with a disputed function that is found in enteropathogenic Escherichia coli. Here we show that EspG is structurally similar to VirA, a Shigella virulence factor; EspG has a large, conserved pocket on its surface; EspG binds directly to the amino-terminal inhibitory domain of human p21-activated kinase (PAK); and mutations to conserved residues in the surface pocket disrupt the interaction with PAK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235237      PMCID: PMC3040069          DOI: 10.1021/bi1020138

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Single-wavelength anomalous diffraction phasing revisited.

Authors:  L M Rice; T N Earnest; A T Brunger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-11

2.  Assay of Cdc42, Rac, and Rho GTPase activation by affinity methods.

Authors:  Valerie Benard; Gary M Bokoch
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 3.  On the Rho'd: the regulation of membrane protrusions by Rho-GTPases.

Authors:  Markus Ladwein; Klemens Rottner
Journal:  FEBS Lett       Date:  2008-04-28       Impact factor: 4.124

4.  The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold.

Authors:  Andrey S Selyunin; Sarah E Sutton; Bethany A Weigele; L Evan Reddick; Robert C Orchard; Stefan M Bresson; Diana R Tomchick; Neal M Alto
Journal:  Nature       Date:  2010-12-19       Impact factor: 49.962

5.  Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.

Authors:  M Lei; W Lu; W Meng; M C Parrini; M J Eck; B J Mayer; S C Harrison
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

6.  EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.

Authors:  S J Elliott; E O Krejany; J L Mellies; R M Robins-Browne; C Sasakawa; J B Kaper
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 7.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri.

Authors:  Jamaine Davis; Jiawei Wang; Joseph E Tropea; Di Zhang; Zbigniew Dauter; David S Waugh; Alexander Wlodawer
Journal:  Protein Sci       Date:  2008-09-11       Impact factor: 6.725

Review 9.  Pak protein kinases and their role in cancer.

Authors:  Bettina Dummler; Kazufumi Ohshiro; Rakesh Kumar; Jeffrey Field
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 10.  The effector repertoire of enteropathogenic E. coli: ganging up on the host cell.

Authors:  Paul Dean; Brendan Kenny
Journal:  Curr Opin Microbiol       Date:  2009-01-12       Impact factor: 7.934

View more
  15 in total

Review 1.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

2.  Bacterial scaffolds assemble novel higher-order complexes to reengineer eukaryotic cell processes.

Authors:  Cammie F Lesser; John M Leong
Journal:  Sci Signal       Date:  2011-07-05       Impact factor: 8.192

Review 3.  Modulation of epithelial cell polarity by bacterial pathogens.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2017-06-19       Impact factor: 5.691

Review 4.  Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.

Authors:  Elamparithi Jayamani; Eleftherios Mylonakis
Journal:  Virulence       Date:  2014       Impact factor: 5.882

5.  Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.

Authors:  Lila G Glotfelty; Anita Zahs; Kimberley Hodges; Kuangda Shan; Neal M Alto; Gail A Hecht
Journal:  Cell Microbiol       Date:  2014-08-07       Impact factor: 3.715

Review 6.  Manipulation of kinase signaling by bacterial pathogens.

Authors:  Anne Marie Krachler; Andrew R Woolery; Kim Orth
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

7.  Republished: tracing PAKs from GI inflammation to cancer.

Authors:  Kyle Dammann; Vineeta Khare; Christoph Gasche
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

Review 8.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

9.  Enterohaemorrhagic Escherichia coli inhibits recycling endosome function and trafficking of surface receptors.

Authors:  Abigail Clements; Charlotte A Stoneham; R Christopher D Furniss; Gad Frankel
Journal:  Cell Microbiol       Date:  2014-07-07       Impact factor: 3.715

10.  Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection.

Authors:  R Christopher D Furniss; Sabrina Slater; Gad Frankel; Abigail Clements
Journal:  J Mol Biol       Date:  2016-05-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.